Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Lehmann

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
European Urology|June 21, 2002
Age dependent secretion of LH and ACTH in healthy men and patients with erectile dysfunctionHarry Derouet, Jan Lehmann, Bettina Stamm, et al.
Clinical Genitourinary Cancer|October 10, 2006
Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancerJames O Jin, Jan Lehmann, Jerome Taxy, et al.
International Journal of Cancer|February 28, 2008
Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancerSigrun Langbein, Wilma M Frederiks, Axel zur Hausen, et al.
European Urology|February 16, 2006
Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell linesJan Lehmann, Margitta Retz, Sukhvinder S Sidhu, et al.
Journal of Nutritional Science|April 12, 2016
Alterations in energy balance from an exercise intervention with ad libitum food intakeKatarina Melzer, Anne Renaud, Stefanie Zurbuchen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 15, 2003
Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer: a real-time quantification and in situ hybridization studyJoern Kamradt, Carsten Drosse, Sascha Kalkbrenner, et al.
BMC Urology|March 5, 2008
Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cellsHenrik Suttmann, Margitta Retz, Friedrich Paulsen, et al.
BMC Cancer|February 12, 2013
Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapyBastian Keck, Sven Wach, Robert Stoehr, et al.
International Journal of Oncology|September 20, 2002
Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude miceRamona Lensch, Claudia Götz, Christine Andres, et al.
Annals of Surgical Oncology|June 29, 2013
SNAI1 protein expression is an independent negative prognosticator in muscle-invasive bladder cancerBastian Keck, Sven Wach, Peter J Goebell, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
European Urology|June 21, 2002
Age dependent secretion of LH and ACTH in healthy men and patients with erectile dysfunctionHarry Derouet, Jan Lehmann, Bettina Stamm, et al.
Clinical Genitourinary Cancer|October 10, 2006
Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancerJames O Jin, Jan Lehmann, Jerome Taxy, et al.
International Journal of Cancer|February 28, 2008
Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancerSigrun Langbein, Wilma M Frederiks, Axel zur Hausen, et al.
European Urology|February 16, 2006
Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell linesJan Lehmann, Margitta Retz, Sukhvinder S Sidhu, et al.
Journal of Nutritional Science|April 12, 2016
Alterations in energy balance from an exercise intervention with ad libitum food intakeKatarina Melzer, Anne Renaud, Stefanie Zurbuchen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 15, 2003
Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer: a real-time quantification and in situ hybridization studyJoern Kamradt, Carsten Drosse, Sascha Kalkbrenner, et al.
BMC Urology|March 5, 2008
Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cellsHenrik Suttmann, Margitta Retz, Friedrich Paulsen, et al.
BMC Cancer|February 12, 2013
Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapyBastian Keck, Sven Wach, Robert Stoehr, et al.
International Journal of Oncology|September 20, 2002
Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude miceRamona Lensch, Claudia Götz, Christine Andres, et al.
Annals of Surgical Oncology|June 29, 2013
SNAI1 protein expression is an independent negative prognosticator in muscle-invasive bladder cancerBastian Keck, Sven Wach, Peter J Goebell, et al.
Pageof 6